From January 1, 2024 to April 25, 2024, the company has repurchased 986,928 shares, representing 1.56% for $15.64 million. With this, the company has completed the repurchase of 7,807,887 shares, representing 11.78% for $100 million under the buyback announced on November 9, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.9 USD | -1.06% |
|
-0.06% | -0.87% |
Jun. 18 | Cantor Fitzgerald Initiates Innoviva at Overweight Rating | MT |
Jun. 10 | Transcript : Innoviva, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 01:20 PM |
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-0.87% | 1B | |
+51.63% | 798B | |
+41.51% | 633B | |
-5.10% | 356B | |
+19.90% | 328B | |
+9.95% | 304B | |
+17.66% | 244B | |
+3.39% | 227B | |
+10.75% | 216B | |
+6.99% | 166B |
- Stock Market
- Equities
- INVA Stock
- News Innoviva, Inc.
- Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 9, 2022.